Apr 43 minPRESS RELEASEThe Lancet publishes positive results from the PHERGain study in patients with localized HER2-positive breast cancer
Dec 8, 20235 minPRESS RELEASEPress Release: DEBBRAH Cohort 5 and ATRACTIB trial at San Antonio Breast Cancer Symposium